Bowel Disease Clinical Trial Community to Educate Patients About the Process, Including Enrolling

Bowel Disease Clinical Trial Community to Educate Patients About the Process, Including Enrolling
The Crohn's & Colitis Foundation has created a Clinical Trial Community program to bring together patients, healthcare providers, research coordinators and trial investigators to facilitate bowel disease trial development and enrollment. Clinical trial recruitment is an important step in a therapy developer's quest for U.S. Food and Drug Administration and European Commission approval. But it can be challenging, affecting the trial development process. "These recruitment difficulties cause delays in attaining the critical data needed to move the drug development process forward," Michael Osso, the foundation's president and CEO, said in a press release. Those with inflammatory bowel disease, or IBD, and their healthcare providers face several barriers to clinical trial participation, according to a foundation study. These include lack of information about the trials, negative perceptions of them, and lack of doctor-patient communication about them. Only 6 percent of doctors tell their patients about clinical trials, the study reported, citing published sources. In addition, it reported that 40 percent of patients do not fully understand the trial drug testing process. "We know through our research that patients would be willing to participate in clinical trials if they were able to learn more about the purpose and importance of clinical trial researc
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *